The Effect of Exercise and/or Diet on Health Related Parameters

November 26, 2020 updated by: Atlantis Medical University College

The Effect of Exercise and/or Diet Body Composition, Cardiorespiratory Fitness and Blood Parameters Related to Improved Health in Overweight Females.

The study evaluates the effect of exercise and/or diet during on body weight, body composition and health related blood parameters. Participants are overweight sedentary females, allocated to four different groups: Normal diet, Low-carb-high-fat diet, Normal diet + exercise, Low-carb-high-fat diet + exercise.

Study Overview

Status

Completed

Detailed Description

Diet and exercise can both be efficient tools to reduce bodyweight, get healthier body composition and improve many different health related blood parameters such as cholesterol and glucose tolerance.

Exercise has superior effect on skeletal muscle in the context of glucose tolerance, but adherence to exercise program can be a huge challenge for overweight individuals. While exercise has profound effect on metabolic health, diet has been superior when it comes to weight reduction. Previous studies have shown that 5-7% weight loss can improve glucose tolerance, measured as reduced fasting glucose and reduced 2-hour post prandial glucose.

We wish to see if the combination exercise and diet is superior to diet only when it comes to over all health.

Study Type

Interventional

Enrollment (Actual)

57

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Oslo, Norway, 0863
        • Norwegian School of Sports Sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

33 years to 47 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Women
  • Sedentary
  • Premenopausal
  • Caucasian
  • BMI 26.9 - 36.1
  • Age 33-4
  • Living close to, or in Oslo.

Exclusion Criteria:

  • Pregnancy
  • Breast-feeding
  • Smoking or tobacco use
  • Previous medical history of cardio-vascular disease (CVD)
  • Previous medical history of diabetes
  • Previous medical history of endocrine disorder
  • Previous medical history of kidney disease
  • Use of lipid lowering medication
  • Use of diabetes medication

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Normal diet
The group ingests normal diet, recommended by the health authorities
Normal diet recommended by the health authorities
Experimental: LCHF diet
The group ingests LCHF diet, a modified Atkins diet with 70 energy percentage fat
LCHF Diet, a modified Atkins diet with high percentage of fat and very low percentage of karbohydrates
Experimental: Normal diet + exercise
The group ingests normal diet, recommended by the health authorities in addition to exercise program 3x week.
Normal diet recommended by the health authorities
Exercise program - indoor bicycle interval exercise, duration 60 min 3x week
Experimental: LCHF diet + exercise
The group ingests LCHF diet, a modified Atkins diet with 70 energy percentage fat, in addition to exercise program 3x week.
LCHF Diet, a modified Atkins diet with high percentage of fat and very low percentage of karbohydrates
Exercise program - indoor bicycle interval exercise, duration 60 min 3x week

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Area under curve (AUC) glucose
Time Frame: Change from baseline AUC glucose at 10 weeks
AUC glucose measured during an OGTT
Change from baseline AUC glucose at 10 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lipid profile
Time Frame: Change from Baseline lipids at 10 weeks
Measurements of total cholesterol, LDL, HDL, TG
Change from Baseline lipids at 10 weeks
Body composition
Time Frame: Change from baseline values at 10 weeks
Measurement of lean body mass, fat free mass, fat mass, visceral fat, bone mass
Change from baseline values at 10 weeks
Cardiorespiratory fitness
Time Frame: Change from baseline values at 10 weeks
Measurement of peak oxygen uptake
Change from baseline values at 10 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jørgen Jensen, Professor, Norwegian School of Sport Sciences, Section of Physical Performance

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 21, 2014

Primary Completion (Actual)

April 4, 2014

Study Completion (Actual)

April 23, 2014

Study Registration Dates

First Submitted

September 13, 2019

First Submitted That Met QC Criteria

September 20, 2019

First Posted (Actual)

September 24, 2019

Study Record Updates

Last Update Posted (Actual)

November 30, 2020

Last Update Submitted That Met QC Criteria

November 26, 2020

Last Verified

November 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Overweight and Obesity

Clinical Trials on Normal Diet

3
Subscribe